Home » Topics » BioWorld Science

BioWorld Science
RSS

Human Genome Sciences claims VIGF polypeptide technology

July 26, 1996

Ulinastatin claimed by Mochida as skin disorder treatment

July 26, 1996

Chugai describes 24-oxo-22-oxavitamin D3 derivatives

July 26, 1996

SEPA-ibuprofen formulation fares well in phase II trial

July 26, 1996

RPR describes tachykinin NK1 antagonists

July 26, 1996

BMDB shows antinociceptive activity in mouse model

July 26, 1996

Didronel receives 22nd marketing approval

July 19, 1996

Ono's Ono-4057 shows immunosuppressive effects in preclinical trials

July 19, 1996

Lea's Shield demonstrates contraceptive efficacy and safety

July 19, 1996

High continuation rate demonstrated for Norplant in first year of use

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...